J.J. Morton

1.6k total citations · 1 hit paper
18 papers, 1.2k citations indexed

About

J.J. Morton is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, J.J. Morton has authored 18 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 7 papers in Cardiology and Cardiovascular Medicine and 5 papers in Surgery. Recurrent topics in J.J. Morton's work include Electrolyte and hormonal disorders (6 papers), Cardiovascular Function and Risk Factors (4 papers) and Heart Failure Treatment and Management (3 papers). J.J. Morton is often cited by papers focused on Electrolyte and hormonal disorders (6 papers), Cardiovascular Function and Risk Factors (4 papers) and Heart Failure Treatment and Management (3 papers). J.J. Morton collaborates with scholars based in United Kingdom. J.J. Morton's co-authors include Ian Ford, John J.V. McMurray, T. McDonagh, Hugh Tunstall‐Pedoe, David R. Murdoch, HJ Dargie, Paul L. Padfield, Mary L. Forsling, Henry J. Dargie and W H Bain and has published in prestigious journals such as The Lancet, Circulation Research and European Respiratory Journal.

In The Last Decade

J.J. Morton

18 papers receiving 1.2k citations

Hit Papers

Biochemical detection of left-ventricular systolic dysfun... 1998 2026 2007 2016 1998 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.J. Morton United Kingdom 11 916 325 183 154 113 18 1.2k
John H. Burgess Canada 20 567 0.6× 264 0.8× 248 1.4× 91 0.6× 79 0.7× 43 1.0k
Alfons Gegenhuber Austria 18 794 0.9× 281 0.9× 239 1.3× 198 1.3× 121 1.1× 24 1.3k
Alan Maisel United States 24 1.2k 1.3× 241 0.7× 289 1.6× 187 1.2× 149 1.3× 41 1.6k
M. G. Buckley United Kingdom 19 497 0.5× 171 0.5× 116 0.6× 75 0.5× 90 0.8× 50 844
Yoram Shenker United States 17 653 0.7× 222 0.7× 200 1.1× 147 1.0× 127 1.1× 40 1.2k
Kyu-Hyung Ryu South Korea 19 838 0.9× 191 0.6× 209 1.1× 148 1.0× 125 1.1× 65 1.2k
A Coletta United Kingdom 23 1.1k 1.2× 185 0.6× 221 1.2× 61 0.4× 165 1.5× 56 1.5k
Jun Nejima Japan 14 665 0.7× 341 1.0× 132 0.7× 61 0.4× 126 1.1× 51 1.1k
Florence Beauvais France 16 1.2k 1.3× 190 0.6× 195 1.1× 132 0.9× 77 0.7× 40 1.4k
P Pietri Greece 16 421 0.5× 204 0.6× 223 1.2× 118 0.8× 78 0.7× 46 893

Countries citing papers authored by J.J. Morton

Since Specialization
Citations

This map shows the geographic impact of J.J. Morton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.J. Morton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.J. Morton more than expected).

Fields of papers citing papers by J.J. Morton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.J. Morton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.J. Morton. The network helps show where J.J. Morton may publish in the future.

Co-authorship network of co-authors of J.J. Morton

This figure shows the co-authorship network connecting the top 25 collaborators of J.J. Morton. A scholar is included among the top collaborators of J.J. Morton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.J. Morton. J.J. Morton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Toshner, Mark, A. A. Roger Thompson, John B. Irving, et al.. (2008). NT-proBNP Does Not Rise on Acute Ascent to High Altitude. High Altitude Medicine & Biology. 9(4). 307–310. 16 indexed citations
2.
Blyth, Kevin G., Bjoern A. Groenning, Patrick B. Mark, et al.. (2006). NT-proBNP can be used to detect right ventricular systolic dysfunction in pulmonary hypertension. European Respiratory Journal. 29(4). 737–744. 88 indexed citations
3.
McDonagh, Theresa A., A D Cunningham, John J.V. McMurray, et al.. (2001). Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population. Heart. 86(1). 21–26. 23 indexed citations
4.
Murdoch, David, John Byrne, Rosemary Farmer, & J.J. Morton. (1999). Disparity between studies of the stability of BNP in blood: comparison of endogenous and exogenous peptide. Heart. 81(2). 212–213. 10 indexed citations
5.
McDonagh, T., David R. Murdoch, J.J. Morton, et al.. (1998). Biochemical detection of left-ventricular systolic dysfunction. The Lancet. 351(9095). 9–13. 781 indexed citations breakdown →
6.
Webb, David J., Per Manhem, B Leckie, et al.. (1989). Severe hypotension with bradycardia during renin inhibition with H142 in sodium deplete man.. PubMed. 3(4). 227–32. 2 indexed citations
7.
Malatino, Lorenzo, A. M. M. Cumming, G P Hodsman, et al.. (1986). Factors Affecting Renal Vein Renin Ratio in Renal Artery Stenosis. ˜The œNephron journals/Nephron journals. 44(1). 68–72. 3 indexed citations
8.
MacGregor, G. A., Nirmala D. Markandu, J Bayliss, et al.. (1981). Non-sulfhydryl-containing angiotensin-converting enzyme inhibitor (MK421): evidence for role of renin system in normotensive subjects.. BMJ. 283(6288). 401–403. 63 indexed citations
9.
Champion, M C, Paul L. Padfield, & J.J. Morton. (1980). Response of antidiuretic hormone to chlorpropamide.. BMJ. 281(6241). 645.1–645. 4 indexed citations
10.
Taylor, Kenneth M., W H Bain, & J.J. Morton. (1980). The role of angiotensin II in the development of peripheral vasoconstriction during open-heart surgery. American Heart Journal. 100(6). 935–937. 36 indexed citations
11.
Padfield, Paul L. & J.J. Morton. (1979). Potassium in the syndrome of inappropriate antidiuretic hormone secretion. Postgraduate Medical Journal. 55(648). 721–722. 1 indexed citations
12.
Brown, J. J., A. F. Lever, J. I. S. Robertson, et al.. (1979). Are Idiopathic Hyperaldosteronism and Low-Renin Hypertension Variants of Essential Hypertension?. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 16(1-6). 380–388. 10 indexed citations
13.
Morton, J.J. & A. J. G. Riegger. (1978). A NOVEL EXTRACTION METHOD FOR PLASMA VASOPRESSIN AND ITS APPLICATION IN A RADIOIMMUNOASSAY. Journal of Endocrinology. 77(2). 277–278. 17 indexed citations
14.
Beevers, DG, et al.. (1977). Angiotensin II in essential hypertension.. BMJ. 1(6058). 415–415. 30 indexed citations
16.
Morton, J.J., Paul L. Padfield, & Mary L. Forsling. (1975). A RADIOIMMUNOASSAY FOR PLASMA ARGININE-VASOPRESSIN IN MAN AND DOG: APPLICATION TO PHYSIOLOGICAL AND PATHOLOGICAL STATES. Journal of Endocrinology. 65(3). 411–424. 92 indexed citations
17.
Davies, D. L., J. J. Brown, R. Fräser, et al.. (1974). A Study of the Renin-Angiotensin System in the Nephrotic Syndrome. ˜The œNephron journals/Nephron journals. 12(4). 233–240. 22 indexed citations
18.
Morton, J.J. & Marion Waite. (1972). THE POSSIBLE RELATIONSHIP BETWEEN THE AFFINITY OF ARGININE-VASOPRESSIN ANTIBODIES AND THE DEGREE OF POLYURIA AND POLYDIPSIA IN ACTIVELY IMMUNIZED RABBITS. Journal of Endocrinology. 54(3). 523–524. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026